PAXLOVID

Anthony Fauci, the nation’s top infectious diseases doctor, said he is experiencing a rebound of COVID-19 symptoms after taking Pfizer’s antiviral drug Paxlovid. Fauci, 81, contracted COVID-19 earlier this month, and while his symptoms were initially “minimal,” he was prescribed a five-day course of Paxlovid when they worsened because of his age. Paxlovid is the…

There’s only one COVID metric trending upward in Michigan lately – and it’s not necessarily a bad one: the availability of therapeutics. COVID cases and hospitalizations continue to decrease in Michigan. And people experiencing severe illness have a slew of drugs to help out: Paxlovid, Bebtelovimab, Evusheld, Molnupiravir and Sotrovimab are the most common.

Dr. Ashish Jha, the White House COVID-19 response coordinator, joined "CBS Mornings" to discuss the state of the pandemic.

Dr. Ashish Jha, the White House COVID-19 response coordinator, joined "CBS Mornings" to discuss the state of the pandemic.

PORTAGE, MI -- Pfizer is planning to invest another $120 million into its Kalamazoo-area manufacturing facility in an effort to expand production of its antiviral COVID drug, Paxlovid. Pfizer announced plans to expand manufacturing capacity of Paxlovid last month, and shared more details Monday, June 6, during a press event at the company’s Portage campus. The latest expansion announcement follows a $450 million investment Pfizer made into the Portage site in 2021. Whitmer toured the plant in February 2021 as Pfizer continued to distribute its COVID-19 vaccine. Read more on MLive:How long does COVID-19 vaccine protection last?

As more Covid patients take the antivirals, US researchers should take the opportunity to find out exactly who benefits.

Rebound symptoms have been reported to occur two to eight days after a patient initially recovers.

Rebound symptoms have been reported to occur two to eight days after a patient initially recovers.

The moves come in the midst of a surge of COVID hospitalizations among the oldest Americans.

The nation's first federally backed test-to-treat site is opening Thursday in Rhode Island, with more set to open in the coming weeks.

Between “Paxlovid rebound” and “Paxlovid mouth,” there’s plenty more to learn about the lifesaving antiviral COVID treatment.

The White House has announced more steps to make the antiviral treatment Paxlovid more accessible across the U.S. as it projects COVID-19 infections will continue to spread over the summer travel season.

PORTAGE, MI -- Pharmaceutical company Pfizer plans to expand its Kalamazoo-area facility to increase manufacturing capabilities for an oral COVID-19 treatment known as Paxlovid. Expansion of the company’s largest manufacturing location is expected to create hundreds of “high-skilled” STEM job, Pfizer announced Tuesday, May 24. Pfizer’s oral COVID treatment, Paxlovid, is available for people 12 and older with mild to moderate COVID-19 who are considered high risk of severe illness. Pfizer plans to unveil its facility expansion plans Monday, June 6, from its location at 7000 Portage Road in Portage. If you have any COVID-19 questions that you’d like answered, please submit them to covidquestions@mlive.com to be considered for future MLive reporting.

The antiviral drug is prescribed to those at risk of severe disease. It's been credited with reducing hospitalizations. But then there's the "Paxlovid rebound."

The second Global COVID-19 Summit aimed to refocus the world's attention on the pandemic. Here's what governments and members of the private and public sector pledged to do.

Invention is easily overrated, and implementation is often underrated.

The head of the World Health Organization has called on Pfizer to make its COVID-19 treatment more widely available in poorer countries.

A small number of COVID-19 patients are relapsing after taking Pfizer's antiviral pill, raising questions about the drug at the center of the U.S. response effort.

The Kentucky Derby is the next major sporting event to move a step closer to normalcy after two years of upheaval in the COVID-19 pandemic.

If symptoms return, FDA says there's "no evidence" taking more Paxlovid helps.

Prescriptions for Pfizer’s Covid-19 antiviral are skyrocketing, but it remains unclear how much the drug helps vaccinated patients — especially if they are at low risk of serious disease.

Pfizer said it sold $13.2 billion of its Covid vaccine and $1.5 billion of its antiviral treatment Paxlovid.

A pill that will help Covid-19 patients avert life-threatening illness has been something of a holy grail for doctors and drugmakers. The earliest therapeutics shown to help have typically been administered to patients via a transfusion or once they have become sick enough to require hospitalization. Two years after the first Covid cases were reported in China, the pill-based treatment Paxlovid emerged, offering a huge advance. Intended for newly infected patients at risk of developing severe di

A pill that will help Covid-19 patients avert life-threatening illness has been something of a holy grail for doctors and drugmakers. The earliest therapeutics shown to help have typically been administered to patients via a transfusion or once they have become sick enough to require hospitalization. Two years after the first Covid cases were reported in China, the pill-based treatment Paxlovid emerged, offering a huge advance. Intended for newly infected patients at risk of developing severe di

During a recent appearance on Fox News, Senator Rand Paul (R-KY) spoke with Sean Hannity about best practices regarding COVID-19 treatment. The conversation came in the wake of Vice President Kamala Harris recently announcing that she tested positive for COVID-19. According to a spokesperson, Harris, who is vaccinated and double boosted, is currently taking Pfizer’s antiviral pill, Paxlovid.

COVID-19 patients have two treatment options that can be taken at home.

In the wake of the Omicron variant wave over the winter, more than half of Americans are estimated to have antibodies from a previous infection.

Supply of Paxlovid was initially very limited, but as COVID cases across the country have fallen and manufacturing has increased, it's more abundant.

Harris has no symptoms and has not been a close contact to President Biden in recent days due to travel, her office said.

The White House has announced plans to let thousands of participating pharmacies directly order highly effective COVID-19 treatments like Paxlovid antiviral pills.

President Joe Biden’s administration is taking steps to expand availability of the life-saving COVID-19 antiviral treatment Paxlovid.

President Joe Biden's administration is taking steps to expand availability of the life-saving COVID-19 antiviral treatment Paxlovid, as it seeks to reassure doctors that there is ample supply for people at high risk of severe illness or death from the virus. Paxlovid, produced by Pfizer, was first approved in December. The White House is now moving to raise awareness of the pill and taking steps to make it easier to access.

Many have struggled to get Paxlovid pills amid the latest wave of infections driven by the highly transmissible omicron subvariant BA.2.

The antiviral pill is available to patients older than 12 who have tested positive for COVID and are at risk for developing a severe case of the disease.

Paxlovid was initially very limited, but as COVID-19 cases across the country have fallen and manufacturing has increased it is now far more abundant.

President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed.

Pfizer expects to start starting supplying the antiviral pills, Paxlovid, to UNICEF starting next month and will continue to do so through the end of the year.

COVID-19 patients now have new treatments they can take at home to stay out of the hospital — if doctors get the pills to them fast enough.

High-risk COVID-19 patients now have new treatments they can take at home to stay out of the hospital — if doctors get the pills to them fast enough. Health systems around the country are rushing out same-day prescription deliveries. The goal is to get patients started on either Pfizer’s Paxlovid tablets or Merck’s molnupiravir capsules within five days of symptoms appearing.

Many people want to know what to expect next as we enter the third year of the COVID pandemic.

The White House launched its “test to treat” COVID initiative on Monday.

The drug company announced Wednesday it has started a clinical trial for Paxlovid in kids ages 6 to 17.

The drug company announced Wednesday it has started a clinical trial for Paxlovid in kids ages 6 to 17.

Pfizer’s new COVID-19 treatment came with a catch when it debuted late last year: It can take months to make the tablets.

Several drug companies are working on antivirals that promise to be easier to use.

A pill that will help Covid-19 patients avert life-threatening illness has been something of a holy grail for doctors and drugmakers. The earliest therapeutics shown to help have typically been administered to patients via a transfusion or once they have become sick enough to require hospitalization. Two years after the first Covid cases were reported in China, two pill-based treatments have emerged that even skeptical scientists are hailing as potentially huge advances. Intended for newly infec

A pill that will help Covid-19 patients avert life-threatening illness has been something of a holy grail for doctors and drugmakers. The earliest therapeutics shown to help have typically been administered to patients via a transfusion or once they have become sick enough to require hospitalization. Two years after the first Covid cases were reported in China, two pill-based treatments have emerged that even skeptical scientists are hailing as potentially huge advances. Intended for newly infec

A pill that will help Covid-19 patients avert life-threatening illness has been something of a holy grail for doctors and drugmakers. The earliest therapeutics shown to help have typically been administered to patients via a transfusion or once they have become sick enough to require hospitalization. Two years after the first Covid cases were reported in China, two pill-based treatments have emerged that even skeptical scientists are hailing as potentially huge advances. Intended for newly infec

Pfizer is taking a look at the efficacy of Paxlovid in children ages 6 to 18.

COVID-19 vaccine sales boosted Pfizer earnings well past fourth-quarter expectations, but the drugmaker has set a lower-than-expected bar for 2022.

With the eligibility criteria for antivirals expanding to include more at-risk Michiganders, state health officials are urging those that test positive for

With the eligibility criteria for antivirals expanding to include more at-risk Michiganders, state health officials are urging those that test positive for

NPR has obtained the government's $5.3 million contract for the first 10 million courses of Paxlovid, an antiviral pill for COVID-19. Here's what's in it.

The European Medicines Agency has recommended Paxlovid for high-risk adult patients who don't require supplemental oxygen.

The European Medicines Agency has recommended Paxlovid for high-risk adult patients who don't require supplemental oxygen.

The European Medicines Agency has recommended Paxlovid for high-risk adult patients who don't require supplemental oxygen.

The long-running case of a former deep-sea treasure hunter marking his sixth year in jail for refusing to disclose the whereabouts of missing gold coins has hit yet another roadblock.

On Monday, prosecutors will try to prove that Calif. lawyer Michael Avenatti cheated porn star Stormy Daniels out of $300,000 in book proceeds. Both Daniels and Avenatti made headlines after filing lawsuits against former President Donald Trump.

For COVID-19 therapies, there is limited supply and high demand, meaning it is difficult for most to access new antiviral pills and monoclonal antibodies. The window is a bit longer, 5 to 10 days, for monoclonal antibodies, more readily available. RELATED: Monoclonal antibodies even more limited as omicron overtakes delta; new antiviral pills also scarceThe antibodies, said to reduce chances of hospitalization and death by 70%, should be considered for patients who are in eligible lower risk tiers. There are three available monoclonal antibodies. “Our patients shouldn’t be counting on monoclonal antibodies,” Dr. Gordana Simeunovic, an infectious disease physician and head of Grand Rapids-based Spectrum Health’s mAbs program, said earlier this month.

South Korea has received its first supply of Pfizer’s antiviral COVID-19 pills to treat patients with mild or moderate symptoms.

Michigan health officials say the state has received its first shipment of newly authorized COVID-19 pill treatments, but it’ll only be prescribed in certain situations due to limited supply.

GRAND RAPIDS, MI — A “very minimal” supply of home COVID-19 treatment pills have arrived in Michigan and are being distributed at pharmacies across the state, according to the Michigan Department of Health and Human Services (MDDHS). MDHHS spokesperson Lynn Sutfin said Friday, Jan. 7 that 7,080 treatment courses of Merk’s Molnupiravir arrived in Michigan Thursday evening, and 1,600 treatment courses of Pfizer’s Paxlovid are also now in the state. The pills, which require a prescription, have been shown to reduce hospitalization and death in patients with the infectious respiratory disease. Sutfin said Molnupiravir has limited availability at all Meijer pharmacies, based on supply, as well as select retail pharmacies in areas not served by Meijer, based on supply. “Pfizer’s pill, Paxlovid, is likely to become the first-choice treatment against the virus, because of its superior benefits and milder side effects,” the news service said.

With the new order, the U.S. has committed to purchase 20 million courses total from Pfizer.

Israel has approved a fourth vaccine dose for people most vulnerable to COVID-19, becoming one of the first countries to do so as it braces for a wave of infections fueled by the omicron variant.

Newly infected COVID-19 patients have two new treatment options that can be taken at home.

Two antiviral pills are the latest additions to the handful of therapies to treat COVID-19 in the U.S. The Food and Drug Administration authorized the drugs from Merck and Pfizer as the first treatments that patients can take at home to treat mild-to-moderate symptoms.

The U.S. has authorized the first pill against COVID-19, a Pfizer drug that Americans can take at home to reduce the risk of hospitalization and death.